XSS(SH:600117)2020-10-26 16:00Financial Performance - Net profit attributable to shareholders of the listed company was ¥9,529,055.69, a decrease of 89% year-on-year[11]. - The company reported a net loss attributable to shareholders after deducting non-recurring gains and losses of ¥265,492,372.04, worsening by 35.68% year-on-year[11]. - The company reported a net profit attributable to shareholders of the parent company of RMB 9,529,055.69, a decrease of 89.00% compared to RMB 86,599,099.74, mainly due to a reduction in shareholding after introducing strategic investors[24]. - The company reported a net loss of approximately ¥2.09 billion, slightly improved from a loss of ¥2.10 billion in the previous year[36]. - The net profit for Q3 2020 was ¥20,128,962.54, compared to ¥13,315,283.52 in Q3 2019, indicating a year-over-year increase of 51.5%[53]. - The net profit attributable to the parent company for the current period was -¥14,101,954.49, compared to a profit of ¥28,130,604.28 in the same period last year, indicating a significant decline[57]. - The total comprehensive income for the current period was -¥146,390,096.07, compared to ¥106,488,290.46 in the same period last year, marking a decline of approximately 237%[63]. - The total profit for the current period was -¥146,390,096.07, compared to a profit of ¥106,488,290.46 in the same period last year, indicating a significant loss[63]. Revenue and Income - Operating income for the first nine months was ¥6,891,353,753.30, reflecting a growth of 4.65% compared to the same period last year[11]. - Total revenue for Q3 2020 reached ¥2,664,044,907.30, an increase of 21.1% compared to ¥2,197,682,555.07 in Q3 2019[49]. - The total operating revenue for Q3 2020 was ¥3,155,564,783.73, an increase from ¥2,800,264,424.74 in Q3 2019, representing a growth of approximately 12.7%[61]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥21,372,393,643.74, an increase of 1.73% compared to the end of the previous year[11]. - Total current assets amounted to approximately ¥7.65 billion, an increase of 8.33% from ¥7.06 billion on December 31, 2019[31]. - Total non-current assets decreased to approximately ¥13.72 billion, down 1.61% from ¥13.95 billion in the previous year[35]. - Current liabilities increased to approximately ¥14.22 billion, a rise of 36.00% from ¥10.40 billion in the previous year[36]. - Total liabilities amounted to approximately ¥16.46 billion, up 2.13% from ¥16.11 billion as of December 31, 2019[36]. - The total liabilities increased to ¥13,691,838,055.29 from ¥13,382,509,712.26, reflecting a rise of 2.3%[46]. - Total liabilities reached 16,114,933,144.58 RMB, with current liabilities totaling 10,396,281,460.68 RMB[81]. Cash Flow - Net cash flow from operating activities increased by 59.52% year-on-year, totaling ¥617,669,587.31[11]. - Cash flow from financing activities showed a significant decline of 807.58% to -RMB 855,228,649.03, primarily due to the repayment of financing loans[26]. - The cash inflow from operating activities for the first three quarters of 2020 was CNY 3,673,573,444.92, an increase of 33.3% compared to CNY 2,753,602,877.03 in the same period of 2019[67]. - The total cash outflow from operating activities was CNY 3,055,903,857.61, compared to CNY 2,366,399,451.35 in the previous year, reflecting a 29.1% increase[67]. - The net cash flow from financing activities was -CNY 855,228,649.03, compared to -CNY 94,231,355.23 in 2019, indicating a significant increase in cash outflow[68]. Shareholder Information - The total number of shareholders reached 55,712 by the end of the reporting period[17]. - The largest shareholder, Xining Special Steel Group Co., Ltd., holds 35.37% of the shares, with 160,600,000 shares pledged[17]. Research and Development - Research and development expenses surged by 2,044.50% to RMB 152,048,923.82 from RMB 7,090,173.06, reflecting increased investment to improve product quality and optimize production processes[24]. - Research and development expenses for Q3 2020 were ¥102,999,058.49, significantly higher than ¥6,387,832.79 in Q3 2019, marking an increase of 1515.5%[49]. - Research and development expenses increased to ¥102,999,058.49 in Q3 2020, up from ¥6,372,928.22 in Q3 2019, reflecting a growth of over 1510%[61]. Future Outlook - The company is focusing on expanding its market presence and enhancing product development strategies moving forward[39]. - Future guidance indicates a cautious outlook, with emphasis on managing liabilities and improving cash flow[89].